Phase 2 Trial "tVNS in SLE" Recruiting as of Sept 2026

A clinical trial update was registered on September 17, 2026, involving a study titled "Transcutaneous Vagus Nerve Stimulation in SLE." The trial, identified as NCT06987565, is listed as Phase 2. Its current status is recruiting, according to the ClinicalTrials.gov record. No results have been posted for this trial as of the listed date. The registration does not specify enrollment numbers, completion timelines, or outcome data beyond the recruiting status. This update pertains to a trial record associated with calcitonin, which carries approved regulatory status. No efficacy or safety conclusions can be drawn from a recruiting status alone. Readers should note that a trial being in the recruiting phase means participant enrollment is ongoing and no findings have been reported yet. Further updates to this trial's status, including any changes in phase or the posting of results, would be reflected in future ClinicalTrials.gov records. For additional background on calcitonin, its approved uses, and related research context, readers can consult the compound overview.